The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge
Abstract
Four common pathological conditions are associated with vaginal discharge: bacterial vaginosis, aerobic vaginitis, candidosis, and the sexually transmitted infection, trichomoniasis. Chlamydial or gonococcal cervical infection may result in vaginal discharge. Vaginal discharge may be caused by a range of other physiological and pathological conditions including atrophic vaginitis, desquamative inflammatory vaginitis, cervicitis, and mucoid ectopy. Psychosexual problems may present with recurrent episodes of vaginal discharge and vulval burning. These need to be considered if tests for specific infections are negative. Many of the symptoms and signs are non-specific and a number of women may have other conditions such as vulval dermatoses or allergic and irritant reactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative maintenance regimen of 200 mg doses of fluconazole weekly for 2 months, then every 2 weeks for 4 months, followed by once-monthly 200 mg doses for another 6 months has also been assessed.22,23”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [23]
In the citing paper
“In most clinical practice guidelines, oral fluconazole is recommended as the first-line treatment.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sherrard et al., 2018
In the citing paper
“The highest prevalence rate (9%) is observed in women aged 25 to 34 years, with a global prevalence of about 7% in 15- to 54-year-old women (Denning et al., 2018; Sherrard et al., 2018; Farr et al., 2021a).”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sherrard et al., 2018
In the citing paper
“Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection, caused by Candida species, which affects women of all ages and ethnic and social background.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sherrard et al., 2018
In the citing paper
“In the European guidelines and according to the Infectious Diseases Society of America guidelines, four or more symptomatic episodes of VVC per year are needed for this diagnosis (Pappas et al., 2015; Sherrard et al., 2018; Farr et al., 2021a; McKloud et al., 2021).”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sherrard et al., 2018
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
Molecular Identification of Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., & Marrazzo, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043802 · Cited by 1,303
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women
Laga, M., Manoka, A. T., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., Alary, M., et al. (1993) · AIDS · doi:10.1097/00002030-199301000-00015 · Cited by 1,139
Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery
COTCH, M. F., PASTOREK, J. G., NUGENT, R. P., HILLIER, S. L., GIBBS, R. S., MARTIN, D. H., ESCHENBACH, D. A., EDELMAN, R., CAREY, C. J., REGAN, J. A., et al. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199707000-00008 · Cited by 836
Bradshaw, C. S., Morton, A. N., Hocking, J. S., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 793
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761
Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysis
Leitich, H., Bodner‐Adler, B., Brunbauer, M., Kaider, A., Egarter, C., & Husslein, P. W. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.339 · Cited by 735
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706
Antibiotics for treating bacterial vaginosis in pregnancy
Brocklehurst, P., Gordon, A., Heatley, E., & Milan, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000262.pub4 · Cited by 609
Research works printed but not linked: 18
- French JI, 1999, Obstet Gynecol, 93, 715
- Gülmezoglu AM, 2011, Cochrane Database Syst Rev, 5, CD000220
- Eckert LO, 1998, Obstet Gynecol, 92, 757
- 10.1111/j.1471-0528.2002.00432.x · DOI
- Hopwood V, 1988, Genitourin Med, 64, 331
- Priestley CJ, 1997, Genitourin Med, 73, 23
- Borchardt KA, 1997, Genitourin Med, 73, 297
- el Naga IF, 2001, J Egypt Soc Parasitol, 31, 647
- Senok AC, 2009, Cochrane Database Syst Rev, 4, CD006289
- Nurbhai M, 2007, Cochrane Database Syst Rev, 4, CD002845
- Cooke G, 2011, Cochrane Database Syst Rev, 5, CD009151
- 2008, Am J Obstet Gynecol, 199, 613
- Dennerstein GJ., 1986, J Reprod Med, 31, 801
- Forna F, 2003, Cochrane Database Syst Rev, 2, CD000218
- Thin RN, 1979, Br J Vener Dis, 55, 354
- Gülmezoglu AM, 2011, Cochrane Database Syst Rev, 5, CD000220
- Amaya-Guio J, 2016, Cochrane Database Syst Rev, 10, CD011701
- Fong IW., 1992, Genitourin Med, 68, 174
Cited by
Sorted by citations
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M. G., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 3,022
The Female Vaginal Microbiome in Health and Bacterial Vaginosis
Chen, X. F., Lu, Y., Chen, T., & Li, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.631972 · Cited by 508
Kalia, N., Singh, J., & Kaur, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-0347-4 · Cited by 308
Bacterial Vaginosis: What Do We Currently Know?
Chacra, L. A., Fenollar, F., & Diop, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.672429 · Cited by 251
Vaginal microbiome and cervical cancer
Kyrgiou, M., & Moscicki, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.005 · Cited by 172
Metadata
- Authors
- Sherrard, J., Wilson, J., Donders, G., Mendling, W., & Jensen, J. S.
- Affiliations
- Buckinghamshire Healthcare NHS Trust (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Antwerp University Hospital (BE)
- Infektionen in Gynäkologie und Geburtshilfe, Wuppertal, Germany
- Statens Serum Institut (DK)
- Corresponding author
- Sherrard, Jackie
- Jensen, Jørgen S
- Venue
- International Journal of STD & AIDS
- Publisher
- SAGE Publications
- Published
- 2018-07-27
- Volume
- 29
- Issue
- 13
- Pages
- 1258-1272
- ISSN
- 0956-4624 (ISSN-L)
- 1758-1052
- OpenAlex
- W2882984619
- Cited by
- 297
- References
- 110
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 39 · 2023: 50 · 2022: 60 · 2021: 42 · 2020: 38 · 2019: 21 · 2018: 1
- FWCI
- 20.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of STD & AIDS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- vaginal discharge, bacterial vaginosis, aerobic vaginitis, vaginal candidiasis, trichomoniasis, chlamydia, gonorrhea, vaginal atrophy, desquamative inflammatory vaginitis, cervicitis, psychosexual problems, sexually transmitted infections, clinical management
- MeSH terms
- Europe, Female, Humans, Sexually Transmitted Diseases, Trichomonas Infections, Vaginitis, World Health Organization, Vaginosis, Bacterial, Guidelines as Topic, Vaginal Discharge
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
